4,177
Views
4
CrossRef citations to date
0
Altmetric
Original Articles

Efficacy of Topical Hemostatic Agents: A Comparative Evaluation of Two Gelatin/Thrombin-Based Hemostatic Matrices in a Porcine Kidney Surgical Model

, , , , , & show all

REFERENCES

  • Vamvakas EC, Blajchman MA. Transfusion-related mortality: the ongoing risks of allogeneic blood transfusion and the available strategies for their prevention. Blood. 2009;113(15):3406–3417. doi: 10.1182/blood-2008-10-167643.
  • Shander A. Financial and clinical outcomes associated with surgical bleeding complications. Surgery. 2007;142(4 Suppl):S20–5. doi: 10.1016/j.surg.2007.06.025.
  • Shander A, Hofmann A, Gombotz H, Theusinger OM, Spahn DR. Estimating the cost of blood: past, present, and future directions. Best Pract Res Clin Anaesthesiol. 2007;21(2):271–289. doi: 10.1016/j.bpa.2007.01.002.
  • Bracey A, Shander A, Aronson S, et al. The use of topical hemostatic agents in cardiothoracic surgery. Annals Thoracic Surg. 2017;104(1):353–360. doi: 10.1016/j.athoracsur.2017.01.096.
  • Tackett SM, Calcaterra D, Magee G, Lattouf OM. Real-world outcomes of hemostatic matrices in cardiac surgery. J Cardiothorac Vasc Anesth. 2014;28(6):1558–1565. doi: 10.1053/j.jvca.2014.05.010.
  • Echave M, Oyaguez I, Casado MA. Use of Floseal®, a human gelatine-thrombin matrix sealant, in surgery: a systematic review. BMC Surg. 2014;14:111. doi: 10.1186/1471-2482-14-111.
  • Pursifull NF, Morey AF. Tissue glues and nonsuturing techniques. Curr Opin Urol. 2007;17(6):396–401. doi: 10.1097/MOU.0b013e3282f0d683.
  • Oz MC, Cosgrove DM, 3rd, Badduke BR, et al. Controlled clinical trial of a novel hemostatic agent in cardiac surgery. The Fusion Matrix Study Group. Annals Thoracic Surg. 2000;69(5):1376–1382. doi: 10.1016/S0003-4975(00)01194-2.
  • Weaver FA, Hood DB, Zatina M, Messina L, Badduke B. Gelatin-thrombin-based hemostatic sealant for intraoperative bleeding in vascular surgery. Ann Vasc Surg. 2002;16(3):286–293. doi: 10.1007/s10016-001-0073-0.
  • Hutchinson RW, Werrlein S, Johns DB, Zhang G, Clymer JW, Kocharian R. An in vivo comparison of hemostatic gelatin matrix products in a Porcine Spleen biopsy-punch model. Surg Technol Int. 2015;27:53–57.
  • Lewis KM, Atlee HD, Mannone AJ, et al. Comparison of two gelatin and thrombin combination hemostats in a porcine liver abrasion model. J Invest Surg. 2013;26(3):141–148. doi: 10.3109/08941939.2012.724519.
  • Coenye KE, Bourgain C, Keibl C, Nurnberger S, van Griensven M. A qualitative morphological comparison of two haemostatic agents in a porcine liver trauma model. Surg Sci. 2013;4:359–364. doi: 10.4236/ss.2013.48071.
  • US National Research Council. Guide for the care and use of laboratory animals. 8th ed. Washington¸ DC: National Academies Press (US); 2011.
  • Lewis KM, Li Q, Jones DS, et al. Development and validation of an intraoperative bleeding severity scale for use in clinical studies of hemostatic agents. Surgery. 2017;161(3):771–781. doi: 10.1016/j.surg.2016.09.022.
  • Stokes ME, Ye X, Shah M, et al. Impact of bleeding-related complications and/or blood product transfusions on hospital costs in inpatient surgical patients. BMC Health Serv Res. 2011;11:135. doi: 10.1186/1472-6963-11-135.
  • Ye X, Lafuma A, Torreton E, Arnaud A. Incidence and costs of bleeding-related complications in French hospitals following surgery for various diagnoses. BMC Health Serv Res. 2013;13:186. doi: 10.1186/1472-6963-13-186.
  • Faivre P, Laplante S, Kreuwel H. Multi European country cost consequence comparison of Floseal matrix and Surgiflo thrombin in major and severe spine surgeries. Value Health. 2015;18(7):A370. doi: 10.1016/j.jval.2015.09.748.
  • Makhija D, Rock M, Ikeme S, et al. Cost-consequence analysis of two different active flowable hemostatic matrices in spine surgery patients. J Med Econ. 2017;20(6):606–613. doi: 10.1080/13696998.2017.1292916.
  • Makhija D, Rock M, Xiong Y, et al. Cost-consequence analysis of different active flowable hemostatic matrices in cardiac surgical procedures. J Med Econ. 2017;20(6):565–573. doi: 10.1080/13696998.2017.1284079.
  • Nogueira L, Katz D, Pinochet R, Kurta JM, Coleman JA. Comparison of gelatine matrix-thrombin sealants used during laparoscopic partial nephrectomy. BJU Int. 2008;102(11):1670–1674. doi: 10.1111/j.1464-410X.2008.07926.x.
  • Gazzeri R, Galarza M, Alfier A. Safety biocompatibility of gelatin hemostatic matrix (Floseal and Surgiflo) in neurosurgical procedures. Surg Technol Int. 2012;22:49–54.
  • Landi A, Gregori F, Marotta N, Delfini R. Efficacy, security, and manageability of gelified hemostatic matrix in bleeding control during thoracic and lumbar spine surgery: FloSeal versus Surgiflo. J Neurol Surg A Cent Eur Neurosurg. 2016;77(2):139–143.